Sagimet Biosciences Statistics
Total Valuation
SGMT has a market cap or net worth of $106.57 million. The enterprise value is -$33.13 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SGMT has 32.20 million shares outstanding. The number of shares has increased by 81.85% in one year.
| Current Share Class | 30.67M |
| Shares Outstanding | 32.20M |
| Shares Change (YoY) | +81.85% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.18% |
| Owned by Institutions (%) | 41.37% |
| Float | 20.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.76 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.34, with a Debt / Equity ratio of 0.00.
| Current Ratio | 20.34 |
| Quick Ratio | 20.13 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.72% and return on invested capital (ROIC) is -24.90%.
| Return on Equity (ROE) | -34.72% |
| Return on Assets (ROA) | -24.05% |
| Return on Invested Capital (ROIC) | -24.90% |
| Return on Capital Employed (ROCE) | -47.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.08M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.45% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -25.45% |
| 50-Day Moving Average | 3.18 |
| 200-Day Moving Average | 4.00 |
| Relative Strength Index (RSI) | 53.57 |
| Average Volume (20 Days) | 570,006 |
Short Selling Information
The latest short interest is 3.89 million, so 12.07% of the outstanding shares have been sold short.
| Short Interest | 3.89M |
| Short Previous Month | 3.83M |
| Short % of Shares Out | 12.07% |
| Short % of Float | 18.96% |
| Short Ratio (days to cover) | 7.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -65.55M |
| Pretax Income | -27.92M |
| Net Income | -57.11M |
| EBITDA | n/a |
| EBIT | -65.55M |
| Earnings Per Share (EPS) | -$1.78 |
Full Income StatementBalance Sheet
The company has $144.57 million in cash and $39,000 in debt, giving a net cash position of $144.53 million or $4.49 per share.
| Cash & Cash Equivalents | 144.57M |
| Total Debt | 39,000 |
| Net Cash | 144.53M |
| Net Cash Per Share | $4.49 |
| Equity (Book Value) | 138.99M |
| Book Value Per Share | 4.32 |
| Working Capital | 138.89M |
Full Balance SheetCash Flow
| Operating Cash Flow | -50.76M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |